News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
610,790 Results
Type
Article (46721)
Company Profile (237)
Press Release (563832)
Multimedia
Podcasts (71)
Webinars (11)
Section
Business (166037)
Career Advice (2060)
Deals (27896)
Drug Delivery (107)
Drug Development (85569)
Employer Resources (157)
FDA (15149)
Job Trends (13279)
News (297697)
Policy (27620)
Tag
Academia (2723)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (92)
Alliances (44234)
ALS (97)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (146)
Approvals (15117)
Artificial intelligence (281)
Autoimmune disease (26)
Automation (16)
Bankruptcy (242)
Best Places to Work (10906)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (178)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (295)
Cancer (2386)
Cardiovascular disease (202)
Career advice (1716)
Career pathing (30)
CAR-T (168)
Cell therapy (455)
Cervical cancer (21)
Clinical research (70045)
Collaboration (858)
Compensation (455)
Complete response letters (28)
COVID-19 (2756)
CRISPR (42)
C-suite (239)
Cystic fibrosis (104)
Data (2252)
Decentralized trials (2)
Denatured (21)
Depression (54)
Diabetes (278)
Diagnostics (6253)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (37)
Drug discovery (122)
Drug pricing (112)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (63066)
Editorial (41)
Employer branding (20)
Employer resources (133)
Events (92363)
Executive appointments (694)
FDA (16429)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (113)
Generative AI (27)
Gene therapy (334)
GLP-1 (775)
Government (4175)
Grass and pollen (6)
Guidances (65)
Healthcare (18185)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (138)
Indications (30)
Infectious disease (2912)
Inflammatory bowel disease (149)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (91)
Interviews (367)
IPO (13531)
IRA (44)
Job creations (2759)
Job search strategy (1446)
Kidney cancer (11)
Labor market (34)
Layoffs (455)
Leadership (19)
Legal (5289)
Liver cancer (79)
Lung cancer (340)
Lymphoma (158)
Machine learning (7)
Management (51)
Manufacturing (296)
MASH (74)
Medical device (12339)
Medtech (12342)
Mergers & acquisitions (14934)
Metabolic disorders (735)
Multiple sclerosis (86)
NASH (22)
Neurodegenerative disease (109)
Neuropsychiatric disorders (32)
Neuroscience (2051)
NextGen: Class of 2025 (6212)
Non-profit (4253)
Now hiring (23)
Obesity (394)
Opinion (241)
Ovarian cancer (78)
Pain (94)
Pancreatic cancer (84)
Parkinson's disease (157)
Partnered (19)
Patents (216)
Patient recruitment (116)
Peanut (50)
People (48718)
Pharmaceutical (52)
Pharmacy benefit managers (18)
Phase I (21973)
Phase II (30806)
Phase III (23096)
Pipeline (1220)
Policy (143)
Postmarket research (2576)
Preclinical (8545)
Press Release (63)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (420)
Real estate (5331)
Recruiting (66)
Regulatory (20327)
Reports (36)
Research institute (2456)
Resumes & cover letters (342)
Rett syndrome (5)
RNA editing (4)
RSV (46)
Schizophrenia (76)
Series A (134)
Series B (87)
Service/supplier (11)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (156)
Sponsored (30)
Startups (3228)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (32)
The Weekly (49)
Vaccines (771)
Venture capitalists (36)
Weight loss (266)
Women's health (36)
Worklife (18)
Date
Today (31)
Last 7 days (842)
Last 30 days (2443)
Last 365 days (31747)
2025 (10447)
2024 (34149)
2023 (38579)
2022 (49437)
2021 (53196)
2020 (51066)
2019 (44060)
2018 (33134)
2017 (30725)
2016 (29369)
2015 (33828)
2014 (25662)
2013 (20714)
2012 (22027)
2011 (22731)
2010 (20893)
Location
Africa (735)
Alabama (52)
Alaska (6)
Arizona (174)
Arkansas (14)
Asia (36614)
Australia (6553)
California (5906)
Canada (1813)
China (528)
Colorado (258)
Connecticut (266)
Delaware (135)
Europe (83447)
Florida (850)
Georgia (194)
Idaho (54)
Illinois (472)
India (23)
Indiana (304)
Iowa (8)
Japan (159)
Kansas (99)
Kentucky (25)
Louisiana (12)
Maine (37)
Maryland (827)
Massachusetts (4381)
Michigan (204)
Minnesota (347)
Mississippi (2)
Missouri (81)
Montana (31)
Nebraska (21)
Nevada (55)
New Hampshire (68)
New Jersey (1616)
New Mexico (29)
New York (1666)
North Carolina (952)
North Dakota (9)
Northern California (2566)
Ohio (199)
Oklahoma (15)
Oregon (37)
Pennsylvania (1291)
Puerto Rico (10)
Rhode Island (30)
South America (1010)
South Carolina (20)
Southern California (2247)
Tennessee (95)
Texas (892)
United States (21996)
Utah (175)
Virginia (146)
Washington D.C. (58)
Washington State (529)
West Virginia (3)
Wisconsin (51)
610,790 Results for "high point clinical trials center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
May 1, 2025
·
6 min read
Press Releases
Privo Technologies Expands CLN-004 Clinical Trial Across Leading U.S. Cancer Centers
April 29, 2025
·
2 min read
glp-1
Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial
The data suggest the high dose nearly closes the efficacy gap with Zepbound.
January 17, 2025
·
3 min read
·
Nick Paul Taylor
Press Releases
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 30, 2025
·
5 min read
Press Releases
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials
March 5, 2025
·
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 10, 2025
·
6 min read
Press Releases
Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma
March 27, 2025
·
6 min read
Press Releases
VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
April 14, 2025
·
6 min read
Press Releases
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
February 18, 2025
·
6 min read
Press Releases
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
February 26, 2025
·
4 min read
1 of 61,079
Next
